1. Home
  2. EVC vs OABI Comparison

EVC vs OABI Comparison

Compare EVC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

SELL

Current Price

$6.51

Market Cap

683.9M

Sector

Industrials

ML Signal

SELL

Logo OmniAb Inc.

OABI

OmniAb Inc.

SELL

Current Price

$4.77

Market Cap

696.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EVC
OABI
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.9M
696.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
EVC
OABI
Price
$6.51
$4.77
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
1.2M
★ 1.2M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
★ 2.97%
N/A
EPS Growth
★ 47.59
6.56
EPS
★ 0.32
N/A
Revenue
★ $536,034,000.00
$18,666,000.00
Revenue This Year
N/A
$87.73
Revenue Next Year
N/A
$25.31
P/E Ratio
$21.16
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.95
$1.32
52 Week High
$13.74
$5.43

Technical Indicators

Market Signals
Indicator
EVC
OABI
Relative Strength Index (RSI) 22.52 55.46
Support Level $2.89 $1.93
Resistance Level $10.09 $5.06
Average True Range (ATR) 0.30 0.33
MACD -0.04 -0.05
Stochastic Oscillator 3.14 64.29

Price Performance

Historical Comparison
EVC
OABI

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: